Onco is an international, peer-reviewed, open access journal covering the whole field of oncotargets and cancer therapies research published quarterly online by MDPI.
  • Open Access—free to download, share, and reuse content. Authors receive recognition for their contribution when the paper is reused.
  • Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 8 days after submission; acceptance to publication is undertaken in 6.7 days (median values for papers published in this journal in the first half of 2021).
  • Recognition of Reviewers: APC discount vouchers, optional signed peer review, and reviewer names published annually in the journal.
  • Onco is a companion journal of Cancers.
Add your e-mail address to receive forthcoming issues of this journal:
Special Issue in Onco
Feature Papers in Onco 2021 Guest Editor: Fred Saad
Deadline: 31 October 2021
Special Issue in Onco
Synthetic Inhibitors of CDK4/6 Activities and Tumor Suppression Guest Editors: Chiaki Takahashi, Jun-ya Kato
Deadline: 31 December 2021
Back to TopTop